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Abstract. We have purified and partially sequenced the
EF-la protein from Xenopus laevis oocytes (EF-laO).
We show that the two cDNA clones isolated by Cop-
pard et al . (Coppard, N. J., K. Poulsen, H. O. Mad-
sen, J. Frydenberg, and B. R C. Clark. 1991. J. Cell
Biol. 112:237-243) do not encode 42Sp50, as claimed
by these authors, but two very similar forms of EF-laO
(EF-Ia0 and EF-la0l) . 42Sp50 is the major protein
component of a 42S nucleoprotein particle that is very
S
EVERAL genes encode elongation factor la (EF-la) in
Xenopus laevis (Djé et al., 1990). The known members
ofthis gene family are EF-lciS, EF-1aO, and 42Sp50.'
EF-1ceS is the somatic form of EF-1a. This form is expressed
in embryos beginning at the mid-blastula transition, and in
adult cells(Krieg et al., 1989; Djé et al., 1990). EF-laO and
42Sp50 are oocyte-specific forms of EF-la. These proteins
differ by several properties. First, the tRNA transfer activity
ofEF-laO is at leastone orderofmagnitude higher than that
of 42Sp50 (Mattaj et al., 1987; Viel et al., 1991) . Second,
EF-laO is not a component of the 42S nucleoprotein parti-
cles, as is 42Sp50 (Picard et al ., 1980 ; Viel et al., 1990) .
Third, EF-1cY0 is present in oocytes of all stages, whereas
42Sp50 is present only in previtellogenic oocytes (Viel et al .,
1990). Fourth, EF-laO is concentrated in the mitochondrial
mass of previtellogenic oocytes (Viel et al ., 1990), whereas
42Sp50 is distributed uniformly in the cell cytoplasm (Mat-
taj et al., 1983 ; Viel et al ., 1990).
In a recent paper Coppard et al. (1991) reported the isola-
tion of two closely related cDNA clones (42Sp48-1 and
42Sp48-2), which they claim encode 42Sp50. In fact, these
clones do not encode 42Sp50 but two very similar forms of
EF-1a0, described by us as EF-lc«O and EF-1a01 (Djé et
al., 1990; these sequence data are available from EMBL/Gen
Bank DDBJ under accession numbers X52976 and X52977) .
Another cDNA clone, also isolated by us encodes 42Sp50
1. In previous publications (Viel et al., 1987, 1990, 1991) 42Sp50 is also
called thesaurin a.
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abundant in previtellogenic oocytes ofX. laevis. 42Sp50
differs from EF-laO not only by its amino acid se-
quence, but also by several properties already reported.
In particular, 42Sp50 has a low EF-la activity. It is
distributed uniformly in the cytoplasm of previtellogenic
oocytes, in contrast to EF-la0 which is concentrated
in a small region of the cytoplasm, known as the mi-
tochondrial mass or Balbiani body.
(Djé et al., 1990 ; these sequence data are available from
EMBL/GenBank/DDBJ under accession number X52975).
To avoid confusion, we present below evidence establish-
ing the correct identity ofthe clones belonging to the EF-lc«
family. We have purified and partially sequenced EF-Icl from
X. laevis ovaries. The amino acid sequence of this protein
corresponds to that of EF-laO cDNA (Djé et al., 1990). It
differs markedly from that encoded by 42Sp50 cDNA (Djé
et al., 1990) and from that of 42Sp50 protein (Viel et al.,
1987).
MaterialsandMethods
EF-la was purified from ovaries of mature females by the procedure of
Miyazaki et al. (1988). Full details of the purification procedure will be
given elsewhere. 428 particles and 42Sp50 were purified from immature
ovaries as described previously (Viel et al., 1991).
The purity ofthe particle and protein preparations was checked by poly-
acrylamide gel electrophoresis (Laemmli, 1970) and inununoblotting using
antibodies raisedagainstArtemia salina EF-la orX. laevis 428 particle pro-
teins (Viel et al., 1990).
Purified EF-la (120 gg/ml) was dialyzed overnight at room temperature
against 500 ml of V8 buffer (125 mM Tris-HCI, pH 6.8, 1 mM EDTA, 0.1%
SDS), concentrated in Centricon 10 (Amicon Corp., Danvers, MA), and
digested for 1 h at 37°C with staphylococcal V8 protease (Miles Laborato-
ries Inc., Naperville, IL) at a protein/enzyme ratio of 10:1 (wt/wt) . Under
these conditions, protease V8 cuts the peptidebonds betweenglutamate and
various amino acids, except praline (Deschamps et al., 1991). Proteolysis
was stopped by boilingthe digest in 10% 2-mercaptoethanol, 2% SDS. The
resulting peptides were separated by SDS-gel electrophoresis, transferred
to a polyvinylidene difluoride membrane (Matsudaira, 1987), and stained
with Coomassie blue. A strip containing the peptide band was cut from the
membrane and submitted to Edman degradation in a gas-phase sequenatorFigure 1 . Electrophoretic analysis of~EF-la purified from mature
ovaries . Lane 1 contains 0.5 lAg of purified EF-la . Lane 2 contains
3.3 jig of 42S particle proteins (42Sp50 and 42Sp43) . Lane 3 con-
tains 1.4 hg ofpurified 42Sp50. Lane4contains protein markers of
known sizes. EF-Ice (lane 1) is slightly contaminated with 42Sp50
contributed by previtellogenic oocytes present in the ovaries .
(model 170-A; AppliedBiosystems Inc., Foster City,CA) coupled to aPTH
analyzer.
Results andDiscussion
EF-la purified from ovaries has a slightly lower elec-
trophoretic mobility than 42Sp50 (Fig . 1) . This confirms
previous observations (Mattaj et al ., 1987; Viel et al ., 1991) .
Themajorband seen in Fig . 1 strongly reacts with an EF-la
antiserum, whereasthe minorband reacts witha42Sp50 an-
tiserum (data not shown) . The latter band corresponds to
42Sp50 contributed by previtellogenic oocytes present in
mature ovaries . When EF-la is purified from defolliculated
vitellogenic oocytes no contamination with 42Sp50 can be
detected (data not shown) .
Several peptides were generated from oocyte EF-la by
digestion with protease V8, purified by gel electrophoresis,
and sequenced by Edmandegradation . Four short stretches
of sequence were elucidated, including a total of 23 residues
(Fig . 2, line 1) . They perfectly match the amino acid se-
quence encoded by EF-laO CDNA (Djé et al ., 1990) and
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1 . EF-laO protein
2 . EF-1U0 CDNA
￿
MGKEKIHINI WIGHVOSGK
3 . EF-1OS CDNA
￿
MGKEKTHINI WIGHVDSGK
4 . 42Sp50 CDNA MTDKAPQKTHLNI VIIGHVDSGK
2 . EF-1a0 CDNA
3 . EF-laS CDNA




KGSFKYAWVL DKLKAERERG ITIDISLWKF ETGKFYITII DAPGHRDFIK 100
KGSFKYAWL DKLKAERERG ITIDISLWKF ETSKYYVTII DAPGHRDFIK
KSSFKFAWIL DKLKAERERG ITIDISLWKF QTNRFTITII DAPGHRDFIK
EF-laO CDNA
￿
NMITGTSQAD CAVLIVAGGV GEFEAGISKN GQTREHALLA FTLGVKQLII 150
EF-laS CDNA
￿
NMITGTSQAD CAVLIVAAGV GEFEAGISKN GQTREHALLA YTLGVKQLIV
42Sp50 CDNA
￿









2 . EF-laO CDNA
3 . EF-IUS CDNA
4 . 42Sp50 CDNA
2 . EF-IOG CDNA
3 . EF-1US CDNA
4 . 42Sp50 cCNA
1 . EF-laC protein
" Y
1 . EF-la0 protein ELP
GVNKMDSTEP PFSQKRFEEI TKEVSAYIKK IGYNPATVPF VPISGWHGDN 200
GINKMDSTEP PYSQKRYEEI VKEVSTYIKK IGYNPDTVAF VPISGWNGDN
CVNKMDLTCP PYSHKRFDEV VRNVMVYLKK IGYNPATIPF VPVSGWTGEN
MLEASTNMPW FKGWKIERKE GNASGVTLLE ALDCIIPPQR PTAKPLRLPL -50
MLEPSPNMPW FKGWKITRKE GSGSGTTLLE ALDCILPPSR PTDKPLRLPL
ISSPSQKMGW FKGWKVKRKD GFTKGQSLLE VLDALVPPVR PANKPLRLPP
2 . EF-laC CDNA
￿
QDVYKIGGIG TVPVGRVETG
3 . EF-laS CDNA
￿
QDVYKIGGIG TVPVGRVETG
4 . 42Sp50 CDNA
￿
AYVYKIGGIG TVPVGRVETG
5 . 42Sp50 prote=c
￿
EXX
2 . EF-1U0 CDNA
￿
EALPGDNVGF NVKNISVKDI
3 . EF-laS CDNA
￿
EAVPGDNVGF NVKNVSVKDV
4 . 92Sp50 CDNA
￿
MAFPGFNIGF NVKNIAAKSL
5 . 42Sp50 prorein MAFPGFNIGF NVKNIAVK
0 O O O
￿
01
2 . EF-laC CDNA
￿
GQISAGYAPV LDCHTAHIAC
3 . EF-laS CDNA
￿
GQIGAGYAPV LDCHTAHIAC
4 . 42Sp50 CDNA
￿
GFIKAGYSPV ICCHTAHITC
2 . EF-laO CDNA
3 . EF-laS CDNA
4 . 42Sp50 CDNA
2 . EF-1a0 CDNA
￿
VTKSAVKAGK -K 462
3 . EP-lnS CDNA
￿
VTKSAQKAAK TK




















RRGNVAGDSK NDPPMQAGSF TAQVIILNHP 350
RRGNVAGDSK NDPPMEAGSF TAQVIILNHP
KRGNVAGNSK SDPPTEASSF TAQVIILNHP
KFAELKQKID RRSGKKLEDD PKFLKSGDAA 400
KFAELKEKID RRSGKKLEDN PKFLKSGDAA
QFAELQEKID RRTGKKLEDN PGLLKSGDAA
IVEMIPGKPM CVESFSDYPP LGRFAVRDMR QTVAVGVIKG VDKKAASSGK 450
IVDMIPGKPM CVESFSDYPP LGRFAVRDMR QTVAVGVIKA VEKKAAGSGK
IITLKPIKPF CVESFSDYPP LGRFAARDLK QTVAVGWKS VEHKAGAAAR
Figure 2 . Alignment of partial sequences of four peptides (over-
lined) derived from EF-la0 with sequences encoded by EF-la0
CDNA (Djé et al ., 1990), EF-loiS CDNA (Krieg et al ., 1989 ; Pöt-
ting et al ., 1990), and 42Sp50 CDNA (Djé et al ., 1990) . The se-
quences of five partially overlapping peptides (underlined) derived
from 42Sp50 (Viel et al ., 1987) are also included in the comparison .
The sequence of EF-la0 CDNA is identical to that of 42Sp48-1
CDNA (Coppard et al ., 1991) . Stars indicate positions at whichthe
EF-1a0 sequences (lines 1and2) differ from the42Sp50 sequences
(lines 4and5) . Filled circles indicate positions at which theEF-la0
sequences (lines 1 and2) differ from theEF-laS sequence (line 3) .
Open circles indicate positions at which the EF-la0 CDNA se-
quence (line 2) differs from the42Sp50 protein sequence (line 5) .
+ indicates the only difference between the CDNA and protein
sequences of 42Sp50 (lines 4 and 5) . X stands for unidentified
residues .
42Sp48-1 CDNA (Coppard et al ., 1991), but differ from the
sequences encodedby EF-lceS CDNA and42Sp50 CDNA in
3 and8positions, respectively (Fig . 2) . The excellent agree-
ment between the42Sp50CDNA and proteinsequences(Fig .
2) justifies our previous identification of this CDNA clone
(Djé et al ., 1990). There can be no doubt that Coppard et
al . (1991) misidentified the cDNAs they studied .
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